BECOME A MEMBER - Get Unlimited CE

  • SIGN IN
  • GET HELP
    •  

    Webinar Details

    Event Type

    Live Online

    Date

    Friday, January 27, 2023

    Time

    10:30 AM - 11:30 AM ET

    Location

    PharmCon Webinar Studio (freeCE.com)

    Credits

    1 Contact Hour(s)

    Target Audience

    Pharmacist, Nurse

    Cost

    $30.00

    • Overview

      Globally, 1 in 5 patients are expected to develop heart failure at some point in their lives. With hospital readmission rates teetering around 50%, care for these patients is often complex and expensive. In recent years, sodium-glucose cotransporter-2 inhibitors (SGLT-2) have become a viable option for managing this patient population. This session seeks to compare and contrast the use of SGLT-2 inhibitors in heart failure with other available treatments, helping the practitioner identify patients who may most benefit from this therapy.


      Handouts

      Slide Document 22053L01_2pp.pdf
      Slide Document 22053L01_6pp.pdf





      Financial Support By

      PharmCon

    • Pharmacist

      Describe current treatment options for Heart Failure with reduced ejection fraction (HFrEF) and Heart Failure with preserved ejection fraction (HFpEF)
      Compare and contrast the benefits of SGLT-2 inhibitors compared to other available therapies for HFrEF and HFpEF
      Select optimal patient for initiating SGLT-2 inhibitors for treatment of heart failure

      Nurse

      Describe current treatment options for Heart Failure with reduced ejection fraction (HFrEF) and Heart Failure with preserved ejection fraction (HFpEF)
      Compare and contrast the benefits of SGLT-2 inhibitors compared to other available therapies for HFrEF and HFpEF
      Select optimal patient for initiating SGLT-2 inhibitors for treatment of heart failure

    • Repeat Presentation

      This presentation was last given on 1/27/2023 10:30 AM

      Future Airings

      There are no future airings of this activity scheduled at this time.

    • Activity Type

      Knowledge

      CE Broker

      20-896513

      Universal Activity Number

      Pharmacist 0798-0000-22-053-L01-P

      Nurse 0798-0000-22-053-L01-N

      ACPE PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

      PharmCon, Inc. is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

      In order to obtain a Statement of Credit, attendees must respond to all randomly-generated participation checks and complete a program evaluation. Attendees may immediately print their Statement of Credit or leave them stored on the website.


    HARDWARE REQUIREMENTS
    Windows 8.1
    Windows 10
    Apple Mac OS X 10.13 or higher
    iOS 10+
    Android 4.3+


    SOFTWARE REQUIREMENTS
    Google Chrome
    Mozilla Firefox

    Log in locally; do not log in using a VPN, cloud server, remote desktop, etc.


    NETWORK REQUIREMENTS
    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection
     
     

    This continuing education activity is held as copyright by PharmCon. Through this notice, PharmCon. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).




    Computer sharing is NOT permitted due to accreditation guidelines on activity monitoring. Credit is earned by one user per device.

     

    LEARN

    LIVE CE

    HOME STUDY CE

    NEWS

    SPECIALTY CERTIFICATES

    SUPPORT

    ABOUT

    RESOURCES

    CE REPORTING

    CAREER ASSISTANCE

    PATIENT CARE INFO

     

    CE ACTIVITY

    ACCOUNT

    (843) 488 5550 Office

    (843) 488 5554 Fax

    info@freeCE.com Email

    www.freeCE.com Web

    201 N. King of Prussia Rd, Suite 370
    Radnor, PA 19087     Address


     

    ©  PharmCon All Rights Reserved.

    Terms & Conditions

    Privacy Policy

    freeCE is a division of PharmCon